Microbiome analysis - From technical advances to biological relevance

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Smith, Michelle I ^a   Turpin, Williams ^a,b   Tyler, Andrea D ^a   Silverberg, Mark S ^a,b   Croitoru, Kenneth ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE TECHNIQUE; FUNCTIONAL STATUS; HOST PATHOGEN INTERACTION; HUMAN; METABOLOMICS; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; REVIEW; SEQUENCE ANALYSIS; TRANSCRIPTOMICS;

EID: 84904859627     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-51     Document Type: Review

References (78)

1. Jones S: Trends in microbiome research. Nat Biotechnol 2013, 31:277.
2. Rey FE, Gonzalez MD, Cheng J, Wu M, Ahern PP, Gordon JI: Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc Natl Acad Sci U S A 2013, 110:13582-7.
3. Stams Alfons J M, Plugge CM: Electron transfer in syntrophic communities of anaerobic bacteria and archaea. Nat Rev Microbiol 2009, 7:568-77.
4. Woese CR: Bacterial evolution. Microbiol Rev 1987, 51:221-71.
5. Woese CR, Fox GE: Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci U S A 1977, 74:5088-90. (Pubitemid 8241042)
6. Weisburg WG, Barns SM, Pelletier DA, Lane DJ: 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991, 173:697-703.
7. Tyler AD, Smith MI, Silverberg MS: Analyzing the Human Microbiome: A 'How To' guide for Physicians. Am J Gastroenterol 2014.
8. Věcarontrovský T, Baldrian P: The variability of the 16S rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PLoS ONE 2013, 8:e57923.
9. Peterson DA, Frank DN, Pace NR, Gordon JI: Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008, 3:417-27. (Pubitemid 351773097)
10. Stearns JC, Lynch Michael D J, Senadheera DB, Tenenbaum HC, Goldberg MB, Cvitkovitch DG, Croitoru K, Moreno-Hagelsieb G, Neufeld JD: Bacterial biogeography of the human digestive tract. Sci Rep 2011, 1:170.
11. Mardis ER: Next-generation sequencing platforms. Annu Rev Anal Chem (Palo Alto Calif) 2013, 6:287-303.
12. Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, Wortman JR, Rusch DB, Mitreva M, Sodergren E, Chinwalla AT, Feldgarden M, Gevers D, Haas BJ, Madupu R, Ward DV, Birren BW, Gibbs RA, Methe B, Petrosino JF, Strausberg RL, Sutton GG, White OR, Wilson RK, Durkin S, Giglio MG, Gujja S, Howarth C, Kodira CD, Kyrpides N, Mehta T, et al.: A catalog of reference genomes from the human microbiome. Science 2010, 328:994-9.
13. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Little AR, et al.: The NIH Human Microbiome Project. Genome Res 2009, 19:2317-23.
14. Manichanh C, Borruel N, Casellas F, Guarner F: The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012, 9:599-608.
15. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW: The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006, 55:1141-9. (Pubitemid 44215574)
16. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Järnerot G, Engstrand L, Tysk C, Jansson JK: Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009, 15:653-60.
17. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L: A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010, 139:1844-1854.e1.
18. Lepage P, Häsler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S, Kupcinskas L, Doré J, Raedler A, Schreiber S: Twin study indicates loss of interaction betweenmicrobiota andmucosa of patients with ulcerative colitis. Gastroenterology 2011, 141:227-36.
19. Wu GD, Bushmanc FD, Lewis JD: Diet, the human gut microbiota, and IBD. Anaerobe 2013, 24:117-20.
20. Steinhart AH, Feagan BG, Wong CJ, Vandervoort M, Mikolainis S, Croitoru K, Seidman E, Leddin DJ, Bitton A, Drouin E, Cohen A, Greenberg GR: Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. Gastroenterology 2002, 123:33-40. (Pubitemid 34747523)
21. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P: Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998, 114:262-7. (Pubitemid 28093532)
22. Petnicki-Ocwieja T, Hrncir T, Liu Y, Biswas A, Hudcovic T, Tlaskalova-Hogenova H, Kobayashi KS: Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A 2009, 106:15813-8.
23. Balfour Sartor R: Enteric Microflora in IBD: Pathogens or Commensals? Inflamm Bowel Dis 1997, 3:230-5.
24. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C: Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012, 13:R79.
25. Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ: Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS ONE 2012, 7:e39242.
26. Tyson GW, Chapman J, Hugenholtz P, Allen EE, Ram RJ, Richardson PM, Solovyev VV, Rubin EM, Rokhsar DS, Banfield JF: Community structure and metabolism through reconstruction of microbial genomes from the environment. Nature 2004, 428:37-43. (Pubitemid 38332350)
27. Venter JC, Remington K, Heidelberg JF, Halpern AL, Rusch D, Eisen JA, Wu D, Paulsen I, Nelson KE, Nelson W, Fouts DE, Levy S, Knap AH, Lomas MW, Nealson K, White O, Peterson J, Hoffman J, Parsons R, Baden-Tillson H, Pfannkoch C, Rogers Y, Smith HO: Environmental genome shotgun sequencing of the Sargasso Sea. Science 2004, 304:66-74. (Pubitemid 38451457)
28. Turnbaugh PJ, Gordon JI: The core gut microbiome, energy balance and obesity. J Physiol (Lond.) 2009, 587:4153-8.
29. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI: Acore gut microbiome in obese and lean twins. Nature 2009, 457:480-4.
30. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R: Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-30.
31. Tatusov RL, Galperin MY, Natale DA, Koonin EV: The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res 2000, 28:33-6. (Pubitemid 30047708)
32. Knight R, Jansson J, Field D, Fierer N, Desai N, Fuhrman JA, Hugenholtz P, van der Lelie, Daniel, Meyer F, Stevens R, Bailey MJ, Gordon JI, Kowalchuk GA, Gilbert JA: Unlocking the potential of metagenomics through replicated experimental design. Nat Biotechnol 2012, 30:513-20.
33. Ni J, Yan Q, Yu Y: How much metagenomic sequencing is enough to achieve a given goal? Sci Rep 2013, 3:1968.
34. Kunin V, Copeland A, Lapidus A, Mavromatis K, Hugenholtz P: A bioinformatician's guide to metagenomics. Microbiol Mol Biol Rev 2008, 72:557-78, Table of Contents.
35. Culligan EP, Sleator RD, Marchesi JR, Hill C: Metagenomics and novel gene discovery: Promise and potential for novel therapeutics. Virulence 2014, 5:399-412.
36. Feng Z, Kallifidas D, Brady SF: Functional analysis of environmental DNA-derived type II polyketide synthases reveals structurally diverse secondary metabolites. Proc Natl Acad Sci USA 2011, 108:12629-34.
37. Rondon MR, August PR, Bettermann AD, Brady SF, Grossman TH, Liles MR, Loiacono KA, Lynch BA, MacNeil IA, Minor C, Tiong CL, Gilman M, Osburne MS, Clardy J, Handelsman J, Goodman RM: Cloning the soil metagenome: a strategy for accessing the genetic and functional diversity of uncultured microorganisms. Appl Environ Microbiol 2000, 66:2541-7. (Pubitemid 30353963)
38. Riesenfeld CS, Goodman RM, Handelsman J: Uncultured soil bacteria are a reservoir of new antibiotic resistance genes. Environ Microbiol 2004, 6:981-9. (Pubitemid 39123252)
39. Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer Morten O A, Dantas G: The shared antibiotic resistome of soil bacteria and human pathogens. Science 2012, 337:1107-11.
40. Gloux K, Leclerc M, Iliozer H, L'Haridon R, Manichanh C, Corthier G, Nalin R, Blottière HM, Doré J: Development of high-throughput phenotyping of metagenomic clones from the human gut microbiome for modulation of eukaryotic cell growth. Appl Environ Microbiol 2007, 73:3734-7. (Pubitemid 46871466)
41. Langille Morgan G I, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber, Rebecca L, Knight R, Beiko RG, Huttenhower C: Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013, 31:814-21.
42. Collins RE, Higgs PG: Testing the infinitely many genes model for the evolution of the bacterial core genome and pangenome. Mol Biol Evol 2012, 29:3413-25.
43. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M: KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40:D109-14.
44. Tatusov RL, Koonin EV, Lipman DJ: A genomic perspective on protein families. Science 1997, 278:631-7. (Pubitemid 27464953)
45. Markowitz VM, Chen IA, Palaniappan K, Chu K, Szeto E, Grechkin Y, Ratner A, Jacob B, Huang J, Williams P, Huntemann M, Anderson I, Mavromatis K, Ivanova NN, Kyrpides NC: IMG: the Integrated Microbial Genomes database and comparative analysis system. Nucleic Acids Res 2012, 40:D115-22.
46. Ferrario C, Ricci G, Milani C, Lugli GA, Ventura M, Eraclio G, Borgo F, Fortina MG: Lactococcus garvieae: where is it from? A first approach to explore the evolutionary history of this emerging pathogen. PLoS ONE 2013, 8:e84796.
47. Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS ONE 2012, 7:e39315.
48. Sorek R, Cossart P: Prokaryotic transcriptomics: a new view on regulation, physiology and pathogenicity. Nat Rev Genet 2010, 11:9-16.
49. Passalacqua KD, Varadarajan A, Ondov BD, Okou DT, Zwick ME, Bergman NH: Structure and complexity of a bacterial transcriptome. J Bacteriol 2009, 191:3203-11.
50. Condon C: Maturation and degradation of RNA in bacteria. Curr Opin Microbiol 2007, 10:271-8.
51. Deutscher MP: Degradation of stable RNA in bacteria. J Biol Chem 2003, 278:45041-4.
52. van Vliet Arnoud H M: Next generation sequencing of microbial transcriptomes: challenges and opportunities. FEMS Microbiol Lett 2010, 302:1-7.
53. Booijink Carien C G M, Boekhorst J, Zoetendal EG, Smidt H, Kleerebezem M, de Vos Willem M: Metatranscriptome analysis of the human fecal microbiota reveals subject-specific expression profiles, with genes encoding proteins involved in carbohydrate metabolism being dominantly expressed. Appl Environ Microbiol 2010, 76:5533-40.
54. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, Affourtit J, Egholm M, Henrissat B, Knight R, Gordon JI: Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A 2010, 107:7503-8.
55. González R, Klaassens ES, Malinen E, de Vos Willem M, Vaughan EE: Differential transcriptional response of Bifidobacterium longum to human milk, formula milk, and galactooligosaccharide. Appl Environ Microbiol 2008, 74:4686-94.
56. O'Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F, Claesson MJ, O'Brien F, Flynn K, Casey PG, Munoz Jose Antonio Moreno, Kearney B, Houston AM, O'Mahony C, Des Higgins G, Shanahan F, Palva A, de Vos Willem M, Fitzgerald GF, Ventura M, O'Toole PW, van Sinderen D: Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved hostcolonization factor. Proc Natl Acad Sci USA 2011, 108:11217-22.
57. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone CA, Knight R, Duncan AE, Bain JR, Muehlbauer MJ, Newgard CB, Heath AC, Gordon JI: The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 2011, 3:106ra106.
58. Lin H, Helsby NA, Rowan DD, Ferguson LR: Using metabolomic analysis to understand inflammatory bowel diseases. Inflamm Bowel Dis 2011, 17:1021-9.
59. Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, Kaplan GG, Vogel HJ, Storr M: Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res 2012, 11:3344-57.
60. Lu K, Knutson CG, Wishnok JS, Fox JG, Tannenbaum SR: Serum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism. J Proteome Res 2012, 11:4916-26.
61. Hisamatsu T, Okamoto S, Hashimoto M, Muramatsu T, Andou A, Uo M, Kitazume MT, Matsuoka K, Yajima T, Inoue N, Kanai T, Ogata H, Iwao Y, Yamakado M, Sakai R, Ono N, Ando T, Suzuki M, Hibi T: Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease. PLoS ONE 2012, 7:e31131.
62. Lindon JC, Holmes E, Nicholson JK: Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 2004, 6:265-72. (Pubitemid 38997127)
63. Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK: Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 2011, 19:349-59.
64. Martin FJ, Dumas M, Wang Y, Legido-Quigley C, Yap, Ivan K S, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC, Sprenger N, Fay LB, Kochhar S, van Bladeren P, Holmes E, Nicholson JK: A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 2007, 3:112.
65. Roediger WE: Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980, 21:793-8.
66. Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK, Bultman SJ: The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011, 13:517-26.
67. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung Y, Wu Y, Schauer P, Smith JD, Allayee H, Tang, W H Wilson, DiDonato JA, Lusis AJ, Hazen SL: Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
68. Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013, 368:1575-84.
69. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang W H Wilson, Bushman FD, Lusis AJ, Hazen SL: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013, 19:576-85.
70. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, Gordon JI: Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A 2011, 108:6252-7.
71. Goodman AL, Wu M, Gordon JI: Identifying microbial fitness determinants by insertion sequencing using genome-wide transposon mutant libraries. Nat Protoc 2011, 6:1969-80.
72. Fritz JV, Desai MS, Shah P, Schneider JG, Wilmes P: From metaomics to causality: experimental models for human microbiome research. Microbiome 2013, 1:14.
73. Smith K, McCoy KD, Macpherson AJ: Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 2007, 19:59-69. (Pubitemid 46810285)
74. Devaraj S, Hemarajata P, Versalovic J: The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem 2013, 59:617-28.
75. Brown JM, Hazen SL: Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Curr Opin Lipidol 2014, 25:48-53.
76. Kostic AD, Howitt MR, Garrett WS: Exploring host-microbiota interactions in animal models and humans. Genes Dev 2013, 27:701-18.
77. Sekirov I, Russell SL, Antunes, L Caetano M, Finlay BB: Gut microbiota in health and disease. Physiol Rev 2010, 90:859-904.
78. Neu J, Lorca G, Kingma Sandra D K, Triplett EW: The intestinal microbiome: relationship to type 1 diabetes. Endocrinol Metab Clin North Am 2010, 39:563-71.